Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. HIV Clinical Trials Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of AIDS disease worldwide
5.1.1.2. Growing investment activities by pharmaceutical and non-profit organizations for HIV clinical trials
5.1.1.3. Rising governmental approvals for HIV drugs and medications
5.1.2. Restraints
5.1.2.1. High costs associated with HIV clinical trials
5.1.3. Opportunities
5.1.3.1. Advancements in HIV clinical trials solutions
5.1.3.2. Significant rise in treatment & diagnosis rate of HIV infections
5.1.4. Challenges
5.1.4.1. Less availability of healthcare infrastructures in underdeveloped countries
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. HIV Clinical Trials Market, by Phase
6.1. Introduction
6.2. Phase I
6.3. Phase II
6.4. Phase III
6.5. Phase IV

7. HIV Clinical Trials Market, by Study Design
7.1. Introduction
7.2. Expanded Access Studies
7.3. Interventional Studies
7.4. Observational Studies

8. HIV Clinical Trials Market, by Sponsor
8.1. Introduction
8.2. Non Profit Organizations
8.3. Pharmaceutical & Biopharmaceutical Companies

9. Americas HIV Clinical Trials Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific HIV Clinical Trials Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa HIV Clinical Trials Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Bionor Holding AS
13.1.2. Charles River Laboratories
13.1.3. Chiltern International Ltd.
13.1.4. Eli Lilly and Company
13.1.5. Gilead Sciences, Inc.
13.1.6. GSK PLC
13.1.7. ICON Plc
13.1.8. IQVIA Inc.
13.1.9. Janssen Global Services, LLC
13.1.10. Novo Nordisk A/S
13.1.11. Parexel International Corporation
13.1.12. Pfizer, Inc.
13.1.13. Pharmaceutical Product Development, LLC
13.1.14. PRA Health Sciences
13.1.15. SGS SA
13.1.16. Syneos Health, Inc.
13.1.17. Wuxi AppTec Inc.
13.2. Key Product Portfolio

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing



List of Figures

FIGURE 1. HIV CLINICAL TRIALS MARKET RESEARCH PROCESS
FIGURE 2. HIV CLINICAL TRIALS MARKET SIZE, 2023 VS 2030
FIGURE 3. HIV CLINICAL TRIALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. HIV CLINICAL TRIALS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. HIV CLINICAL TRIALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. HIV CLINICAL TRIALS MARKET DYNAMICS
FIGURE 7. HIV CLINICAL TRIALS MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
FIGURE 8. HIV CLINICAL TRIALS MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. HIV CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2023 VS 2030 (%)
FIGURE 10. HIV CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. HIV CLINICAL TRIALS MARKET SIZE, BY SPONSOR, 2023 VS 2030 (%)
FIGURE 12. HIV CLINICAL TRIALS MARKET SIZE, BY SPONSOR, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS HIV CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS HIV CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES HIV CLINICAL TRIALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES HIV CLINICAL TRIALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC HIV CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC HIV CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HIV CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HIV CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. HIV CLINICAL TRIALS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. HIV CLINICAL TRIALS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. HIV CLINICAL TRIALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. HIV CLINICAL TRIALS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL HIV CLINICAL TRIALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. HIV CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 6. HIV CLINICAL TRIALS MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. HIV CLINICAL TRIALS MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. HIV CLINICAL TRIALS MARKET SIZE, BY PHASE III, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. HIV CLINICAL TRIALS MARKET SIZE, BY PHASE IV, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. HIV CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 11. HIV CLINICAL TRIALS MARKET SIZE, BY EXPANDED ACCESS STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. HIV CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. HIV CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. HIV CLINICAL TRIALS MARKET SIZE, BY SPONSOR, 2018-2030 (USD MILLION)
TABLE 15. HIV CLINICAL TRIALS MARKET SIZE, BY NON PROFIT ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. HIV CLINICAL TRIALS MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS HIV CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS HIV CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS HIV CLINICAL TRIALS MARKET SIZE, BY SPONSOR, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS HIV CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 21. ARGENTINA HIV CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA HIV CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA HIV CLINICAL TRIALS MARKET SIZE, BY SPONSOR, 2018-2030 (USD MILLION)
TABLE 24. BRAZIL HIV CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL HIV CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL HIV CLINICAL TRIALS MARKET SIZE, BY SPONSOR, 2018-2030 (USD MILLION)
TABLE 27. CANADA HIV CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 28. CANADA HIV CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 29. CANADA HIV CLINICAL TRIALS MARKET SIZE, BY SPONSOR, 2018-2030 (USD MILLION)
TABLE 30. MEXICO HIV CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 31. MEXICO HIV CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 32. MEXICO HIV CLINICAL TRIALS MARKET SIZE, BY SPONSOR, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES HIV CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES HIV CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES HIV CLINICAL TRIALS MARKET SIZE, BY SPONSOR, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES HIV CLINICAL TRIALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC HIV CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC HIV CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC HIV CLINICAL TRIALS MARKET SIZE, BY SPONSOR, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC HIV CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 41. AUSTRALIA HIV CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA HIV CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA HIV CLINICAL TRIALS MARKET SIZE, BY SPONSOR, 2018-2030 (USD MILLION)
TABLE 44. CHINA HIV CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 45. CHINA HIV CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 46. CHINA HIV CLINICAL TRIALS MARKET SIZE, BY SPONSOR, 2018-2030 (USD MILLION)
TABLE 47. INDIA HIV CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 48. INDIA HIV CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 49. INDIA HIV CLINICAL TRIALS MARKET SIZE, BY SPONSOR, 2018-2030 (USD MILLION)
TABLE 50. INDONESIA HIV CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA HIV CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA HIV CLINICAL TRIALS MARKET SIZE, BY SPONSOR, 2018-2030 (USD MILLION)
TABLE 53. JAPAN HIV CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 54. JAPAN HIV CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 55. JAPAN HIV CLINICAL TRIALS MARKET SIZE, BY SPONSOR, 2018-2030 (USD MILLION)
TABLE 56. MALAYSIA HIV CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA HIV CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA HIV CLINICAL TRIALS MARKET SIZE, BY SPONSOR, 2018-2030 (USD MILLION)
TABLE 59. PHILIPPINES HIV CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES HIV CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES HIV CLINICAL TRIALS MARKET SIZE, BY SPONSOR, 2018-2030 (USD MILLION)
TABLE 62. SINGAPORE HIV CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE HIV CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE HIV CLINICAL TRIALS MARKET SIZE, BY SPONSOR, 2018-2030 (USD MILLION)
TABLE 65. SOUTH KOREA HIV CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA HIV CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA HIV CLINICAL TRIALS MARKET SIZE, BY SPONSOR, 2018-2030 (USD MILLION)
TABLE 68. TAIWAN HIV CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN HIV CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN HIV CLINICAL TRIALS MARKET SIZE, BY SPONSOR, 2018-2030 (USD MILLION)
TABLE 71. THAILAND HIV CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 72. THAILAND HIV CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 73. THAILAND HIV CLINICAL TRIALS MARKET SIZE, BY SPONSOR, 2018-2030 (USD MILLION)
TABLE 74. VIETNAM HIV CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM HIV CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM HIV CLINICAL TRIALS MARKET SIZE, BY SPONSOR, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA HIV CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA HIV CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA HIV CLINICAL TRIALS MARKET SIZE, BY SPONSOR, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA HIV CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 81. DENMARK HIV CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 82. DENMARK HIV CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 83. DENMARK HIV CLINICAL TRIALS MARKET SIZE, BY SPONSOR, 2018-2030 (USD MILLION)
TABLE 84. EGYPT HIV CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 85. EGYPT HIV CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 86. EGYPT HIV CLINICAL TRIALS MARKET SIZE, BY SPONSOR, 2018-2030 (USD MILLION)
TABLE 87. FINLAND HIV CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 88. FINLAND HIV CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 89. FINLAND HIV CLINICAL TRIALS MARKET SIZE, BY SPONSOR, 2018-2030 (USD MILLION)
TABLE 90. FRANCE HIV CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 91. FRANCE HIV CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 92. FRANCE HIV CLINICAL TRIALS MARKET SIZE, BY SPONSOR, 2018-2030 (USD MILLION)
TABLE 93. GERMANY HIV CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 94. GERMANY HIV CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 95. GERMANY HIV CLINICAL TRIALS MARKET SIZE, BY SPONSOR, 2018-2030 (USD MILLION)
TABLE 96. ISRAEL HIV CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL HIV CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL HIV CLINICAL TRIALS MARKET SIZE, BY SPONSOR, 2018-2030 (USD MILLION)
TABLE 99. ITALY HIV CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 100. ITALY HIV CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 101. ITALY HIV CLINICAL TRIALS MARKET SIZE, BY SPONSOR, 2018-2030 (USD MILLION)
TABLE 102. NETHERLANDS HIV CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS HIV CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS HIV CLINICAL TRIALS MARKET SIZE, BY SPONSOR, 2018-2030 (USD MILLION)
TABLE 105. NIGERIA HIV CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA HIV CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA HIV CLINICAL TRIALS MARKET SIZE, BY SPONSOR, 2018-2030 (USD MILLION)
TABLE 108. NORWAY HIV CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 109. NORWAY HIV CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 110. NORWAY HIV CLINICAL TRIALS MARKET SIZE, BY SPONSOR, 2018-2030 (USD MILLION)
TABLE 111. POLAND HIV CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 112. POLAND HIV CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 113. POLAND HIV CLINICAL TRIALS MARKET SIZE, BY SPONSOR, 2018-2030 (USD MILLION)
TABLE 114. QATAR HIV CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 115. QATAR HIV CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 116. QATAR HIV CLINICAL TRIALS MARKET SIZE, BY SPONSOR, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA HIV CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA HIV CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA HIV CLINICAL TRIALS MARKET SIZE, BY SPONSOR, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA HIV CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA HIV CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA HIV CLINICAL TRIALS MARKET SIZE, BY SPONSOR, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA HIV CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA HIV CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA HIV CLINICAL TRIALS MARKET SIZE, BY SPONSOR, 2018-2030 (USD MILLION)
TABLE 126. SPAIN HIV CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 127. SPAIN HIV CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 128. SPAIN HIV CLINICAL TRIALS MARKET SIZE, BY SPONSOR, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN HIV CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN HIV CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN HIV CLINICAL TRIALS MARKET SIZE, BY SPONSOR, 2018-2030 (USD MILLION)
TABLE 132. SWITZERLAND HIV CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND HIV CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND HIV CLINICAL TRIALS MARKET SIZE, BY SPONSOR, 2018-2030 (USD MILLION)
TABLE 135. TURKEY HIV CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 136. TURKEY HIV CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 137. TURKEY HIV CLINICAL TRIALS MARKET SIZE, BY SPONSOR, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES HIV CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES HIV CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES HIV CLINICAL TRIALS MARKET SIZE, BY SPONSOR, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM HIV CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM HIV CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM HIV CLINICAL TRIALS MARKET SIZE, BY SPONSOR, 2018-2030 (USD MILLION)
TABLE 144. HIV CLINICAL TRIALS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 145. HIV CLINICAL TRIALS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 146. HIV CLINICAL TRIALS MARKET LICENSE & PRICING